# Genomic Evaluation in Patients With Diffuse Large B Cell Lymphoma After First Relapse/Progression

> **NCT03977623** · — · UNKNOWN · sponsor: **Samsung Medical Center** · enrollment: 200 (estimated)

## Conditions studied

- Lymphoma, Large B-Cell, Diffuse

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT03977623
- **Lead sponsor:** Samsung Medical Center
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2019-09-24
- **Primary completion:** 2022-02-28
- **Final completion:** 2022-02-28
- **Target enrollment:** 200 (ESTIMATED)
- **Last updated:** 2020-03-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03977623

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03977623, "Genomic Evaluation in Patients With Diffuse Large B Cell Lymphoma After First Relapse/Progression". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT03977623. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*